85 research outputs found

    Search for New Physics in Lepton + Photon + X Events with L=305 pb-1 of ppbar Collisions at roots=1.96 TeV

    Get PDF
    We present results of a search for anomalous production of events containing a charged lepton (either electron or muon) and a photon, both with high transverse momentum, accompanied by additional signatures, X, including missing transverse energy (MET) and additional leptons and photons. We use the same kinematic selection criteria as in a previous CDF search, but with a substantially larger data set, 305 pb-1, a ppbar collision energy of 1.96 TeV, and the upgraded CDF II detector. We find 42 Lepton+Photon+MET events versus a standard model expectation of 37.3 +- 5.4 events. The level of excess observed in Run I, 16 events with an expectation of 7.6 +- 0.7 events (corresponding to a 2.7 sigma effect), is not supported by the new data. In the signature of Multi-Lepton+Photon+X we observe 31 events versus an expectation of 23.0 +- 2.7 events. In this sample we find no events with an extra photon or MET and so find no events like the one ee+gg+MET event observed in Run I.Comment: 7 pages, 3 figures, 1 table. Accepted to PR

    Multipurpose silicon photonics signal processor core

    Full text link
    [EN] Integrated photonics changes the scaling laws of information and communication systems offering architectural choices that combine photonics with electronics to optimize performance, power, footprint, and cost. Application-specific photonic integrated circuits, where particular circuits/chips are designed to optimally perform particular functionalities, require a considerable number of design and fabrication iterations leading to long development times. A different approach inspired by electronic Field Programmable Gate Arrays is the programmable photonic processor, where a common hardware implemented by a two-dimensional photonic waveguide mesh realizes different functionalities through programming. Here, we report the demonstration of such reconfigurable waveguide mesh in silicon. We demonstrate over 20 different functionalities with a simple seven hexagonal cell structure, which can be applied to different fields including communications, chemical and biomedical sensing, signal processing, multiprocessor networks, and quantum information systems. Our work is an important step toward this paradigm.J.C. acknowledges funding from the ERC Advanced Grant ERC-ADG-2016-741415 UMWP-Chip, I.G. acknowledges the funding through the Spanish MINECO Ramon y Cajal program. D.P. acknowledges financial support from the UPV through the FPI predoctoral funding scheme. D.J.T. acknowledges funding from the Royal Society for his University Research Fellowship.Pérez-López, D.; Gasulla Mestre, I.; Crudgington, L.; Thomson, DJ.; Khokhar, AZ.; Li, K.; Cao, W.... (2017). Multipurpose silicon photonics signal processor core. Nature Communications. 8(1925):1-9. https://doi.org/10.1038/s41467-017-00714-1S1981925Doerr, C. R. & Okamoto, K. Advances in silica planar lightwave circuits. J. Lightw. Technol. 24, 4763–4789 (2006).Coldren, L. A. et al. High performance InP-based photonic ICs—A tutorial. J. Lightw. Technol 29, 554–570 (2011).Soref, R. The past, present, and future of silicon photonics. IEEE J. Sel. Top. Quantum Electron. 12, 1678–1687 (2006).Bogaerts, W. Design challenges in silicon photonics. IEEE J. Sel. Top. Quantum Electron. 20, 8202008 (2014).Bogaerts, W. et al. Nanophotonic waveguides in silicon-on-insulator fabricated with CMOS technology. J. Lightw. Technol. 23, 401–412 (2005).Smit, M. K. et al. An introduction to InP-based generic integration technology. Semicond. Sci. Technol. 29, 083001 (2014).Leinse, A. et al. TriPleX waveguide platform: low-loss technology over a wide wavelength range. Proc. SPIE 8767, 87670E (2013).Kish, F. et al. From visible light-emitting diodes to large-scale III–V photonic integrated circuits. Proc. IEEE 101, 2255–2270 (2013).Heck, M. J. R. et al. Hybrid silicon photonic integrated circuit technology. IEEE J. Sel. Top. Quantum Electron. 19, 6100117 (2013).Sacher, W. et al. Multilayer silicon nitride-on-silicon integrated photonic platforms and devices. J. Lightw. Technol. 33, 901–910 (2015).Asghari, M. Silicon photonics: A low cost integration platform for datacom and telecom applications. In OFC/NFOEC 2008 – 2008 Conference on Optical Fiber Communication/National Fiber Optic Engineers Conference 1–10 (San Diego, USA, 2008).Melati, D. et al. Integrated all-optical MIMO demultiplexer for mode- and wavelength-division-multiplexed transmission. Opt. Lett. 42, 342–345 (2017).Waterhouse, R. & Novak, D. Realizing 5G: microwave photonics for 5G mobile wireless systems. IEEE Microw. Mag. 16, 84–92 (2015).Marpaung, D. et al. Integrated microwave photonics. Laser Photon. Rev. 7, 506–538 (2013).Iezekiel, S., Burla, M., Klamkin, J., Marpaung, D. & Capmany, J. RF engineering meets optoelectronics: Progress in integrated microwave photonics. IEEE Microw. Mag. 16, 28–45 (2015).Technology focus on microwave photonics. Nat. Photon. 5, 723 (2011).Ghelfi, P. et al. A fully photonics-based coherent radar system. Nature 507, 341–345 (2014).Heideman, R. G. TriPleX™-based integrated optical ring resonators for lab-ona-chip-and environmental detection. IEEE J. Sel. Top. Quantum Electron. 18, 1583–1596 (2012).Estevez, M. C., Alvarez, M. & Lechuga, L. Integrated optical devices for lab-on-a-chip biosensing applications. Laser Photon. Rev. 6, 463–487 (2012).Almeida, V. R., Barrios, C. A., Panepucci, R. & Lipson, M. All-optical control of light on a silicon chip. Nature 431, 1081–1084 (2004).Norberg, E. J., Guzzon, R. S., Parker, J. S., Johansson, L. A. & Coldren, L. A. Programmable photonic microwave filters monolithically integrated in InP/InGaAsP. J. Lightw. Technol. 29, 1611–1619 (2011).Wang, J. et al. Reconfigurable radio-frequency arbitrary waveforms synthesized in a silicon photonic chip. Nat. Commun. 6, 5957 (2015).Hill, M. T. et al. A fast low power optical memory based on coupled micro-ring lasers. Nature 432, 206–209 (2004).Slavík, R. et al. Photonic temporal integrator for all-optical computing. Opt. Express 16, 18202–18214 (2008).Sun, C. et al. A monolithically-integrated chip-to-chip optical link in bulk CMOS. IEEE J. Solid-State Circ. 50, 828–844 (2015).Sun, C. et al. Single-chip microprocessor that communicates directly using light. Nature 528, 534–538 (2015).Assefa, S. et al. in Optical Fibre Communication Conference OMM6, https://www.osapublishing.org/abstract.cfm?uri=OFC-2011-OMM6 (Optical Society of America, 2011).Peruzzo, A. et al. Multimode quantum interference of photons in multiport integrated devices. Nat. Commun. 2, 224 (2011).Bonneau, D. et al. Quantum interference and manipulation of entanglement in silicon wire waveguide quantum circuits. N. J. Phys. 14, 045003 (2012).Metcalf, B. J. et al. Multiphoton quantum interference in a multiport integrated photonic device. Nat. Commun. 4, 1356 (2013).Muñoz, P. et al. in 16th International Conference on Transparent Optical Networks (ICTON), 1–4 (Graz, 2014).Ribeiro, A. et al. Demonstration of a 4×4-port universal linear circuit. Optica 3, 1348–1357 (2016).Liu, W. et al. A fully reconfigurable photonic integrated signal processor. Nat. Photon 10, 190–195 (2016).Graydon, O. Birth of the programmable optical chip. Nat. Photon 10, 1 (2016).Pérez, D., Gasulla, I. & Capmany, J. Software-defined reconfigurable microwave photonics processor. Opt. Express 23, 14640–14654 (2015).Miller, D. A. B. Self-configuring universal linear optical component. Photon. Res. 1, 1–15 (2013).Miller, D. A. B. Self-aligning universal beam coupler. Opt. Express 21, 6360–6370 (2013).Clements, W. R. et al. Optimal design for universal multiport interferometers. Optica 3, 1460–1465 (2016).Zhuang, L., Roeloffzen, C. G. H., Hoekman, M., Boller, K.-J. & Lowery, A. J. Programmable photonic signal processor chip for radiofrequency applications. Optica 2, 854–859 (2015).Capmany, J., Gasulla, I. & Pérez, D. Microwave photonics: The programmable processor. Nat. Photon. 10, 6–8 (2016).Pérez, D., Gasulla., Capmany, J. & Soref, R. A. Reconfigurable lattice mesh designs for programmable photonic processors. Opt. Express 24, 12093–12106 (2016).Madsen, C. K. & Zhao, J. H. Optical Filter Design and Analysis: A Signal Processing Approach. 1st edn. (Wiley, 1999).Jinguji, K. Synthesis of coherent two-port lattice-form optical delay-line circuit. J. Lightw. Technol. 13, 73–82 (1995).Jinguji, K. Synthesis of coherent two-port Optical delay-line circuit with ring waveguides. J. Lightw. Technol. 14, 1882–1898 (1996).Madsen, C. K. General IIR optical filter design for WDM applications using all-pass filters. J. Lightw. Technol. 18, 860–868 (2000).Burla, M. et al. On-chip CMOS compatible reconfigurable optical delay line with separate carrier tuning for microwave photonic signal processing. Opt. Express 19, 21475–21484 (2011).Yariv, A. et al. Coupled resonator optical waveguides: a proposal and analysis. Opt. Lett. 24, 711–713 (1999).Hebner, J. E. et al. Distributed and localized feedback in microresonator sequences for linear and nonlinear optics. J. Opt. Soc. Am. B. 21, 1665–1673 (2004).Fandiño, J. S. et al. A monolithic integrated photonic microwave filter. Nat. Photon. 11, 124–129 (2017).Miller, D. A. B. All linear optical devices are mode converters. Opt. Express 20, 23985–23993 (2012).Reck, M. et al. Experimental realization of any discrete unitary operator. Phys. Rev. Lett. 73, 58–61 (1994).Carolan, J. et al. Universal linear optics. Science 349, 711 (2015).Nielsen, M. A. & Chuang, I. L. Quantum Computation and Quantum Information. 1st edn. (Cambridge University Press, 2001).Miller, D. A. B. Perfect optics with imperfect components. Optica 2, 747–750 (2015).Grillanda, S. et al. Non-invasive monitoring and control in silicon photonics using CMOS integrated electronics. Optica 1, 129–136 (2014)

    Structure and Behavior of Human α-Thrombin upon Ligand Recognition: Thermodynamic and Molecular Dynamics Studies

    Get PDF
    Thrombin is a serine proteinase that plays a fundamental role in coagulation. In this study, we address the effects of ligand site recognition by alpha-thrombin on conformation and energetics in solution. Active site occupation induces large changes in secondary structure content in thrombin as shown by circular dichroism. Thrombin-D-Phe-Pro-Arg-chloromethyl ketone (PPACK) exhibits enhanced equilibrium and kinetic stability compared to free thrombin, whose difference is rooted in the unfolding step. Small-angle X-ray scattering (SAXS) measurements in solution reveal an overall similarity in the molecular envelope of thrombin and thrombin-PPACK, which differs from the crystal structure of thrombin. Molecular dynamics simulations performed with thrombin lead to different conformations than the one observed in the crystal structure. These data shed light on the diversity of thrombin conformers not previously observed in crystal structures with distinguished catalytic and conformational behaviors, which might have direct implications on novel strategies to design direct thrombin inhibitors

    Search for Excited and Exotic Muons in the mu+gamma Decay Channel in p-pbar Collisions at sqrt{s} = 1.96 TeV

    Get PDF
    We present a search for excited and exotic muon states mu*, conducted using an integrated luminosity of 371 pb^{-1} of data collected in p-pbar collisions at sqrt{s} = 1.96 TeV at the Tevatron with the CDF II detector. We search for associated production of mu+mu* followed by the decay mu* -> mu+gamma, resulting in the mu+mu+gamma final state. We compare the data to model predictions as a function of the mass of the excited muon M(mu*), the compositeness energy scale Lambda, and the gauge coupling factor f. No signal above the standard model expectation is observed in the mu+gamma mass spectrum. In the contact interaction model, we exclude 107 < M(mu*) < 853 GeV/c^2 for Lambda = M(mu*); in the gauge-mediated model, we exclude 100 < M(mu) < 410 GeV/c^2 for f/Lambda = 0.01/GeV. These 95% confidence level exclusions extend previous limits and are the first hadron collider results on mu* production in the gauge-mediated model.Comment: Submitted to Phys. Rev. Lett., 7 pages, 4 Figure

    Measurement of the B+ production cross section in pp(-) collisions at root s=1960 GeV

    Get PDF
    We present a new measurement of the B+ meson differential cross section d sigma/dp(T) at root s=1960 GeV. The data correspond to an integrated luminosity of 739 pb(-1) collected with the upgraded CDF detector (CDF II) at the Fermilab Tevatron collider. B+ candidates are reconstructed through the decay B+-\u3e J/psi K+, with J/psi -\u3emu(+)mu(-). The integrated cross section for producing B+ mesons with p(T)\u3e= 6 GeV/c and vertical bar y vertical bar \u3c= 1 is measured to be 2.78 +/- 0.24 mu b

    Measurement of the B+ production cross section in pp(-) collisions at root s=1960 GeV

    Get PDF
    We present a new measurement of the B+ meson differential cross section d sigma/dp(T) at root s=1960 GeV. The data correspond to an integrated luminosity of 739 pb(-1) collected with the upgraded CDF detector (CDF II) at the Fermilab Tevatron collider. B+ candidates are reconstructed through the decay B+-\u3e J/psi K+, with J/psi -\u3emu(+)mu(-). The integrated cross section for producing B+ mesons with p(T)\u3e= 6 GeV/c and vertical bar y vertical bar \u3c= 1 is measured to be 2.78 +/- 0.24 mu b

    Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

    Get PDF
    Background Hypertension can be detected at the primary health-care level and low-cost treatments can effectively control hypertension. We aimed to measure the prevalence of hypertension and progress in its detection, treatment, and control from 1990 to 2019 for 200 countries and territories. Methods We used data from 1990 to 2019 on people aged 30–79 years from population-representative studies with measurement of blood pressure and data on blood pressure treatment. We defined hypertension as having systolic blood pressure 140 mm Hg or greater, diastolic blood pressure 90 mm Hg or greater, or taking medication for hypertension. We applied a Bayesian hierarchical model to estimate the prevalence of hypertension and the proportion of people with hypertension who had a previous diagnosis (detection), who were taking medication for hypertension (treatment), and whose hypertension was controlled to below 140/90 mm Hg (control). The model allowed for trends over time to be non-linear and to vary by age. Findings The number of people aged 30–79 years with hypertension doubled from 1990 to 2019, from 331 (95% credible interval 306–359) million women and 317 (292–344) million men in 1990 to 626 (584–668) million women and 652 (604–698) million men in 2019, despite stable global age-standardised prevalence. In 2019, age-standardised hypertension prevalence was lowest in Canada and Peru for both men and women; in Taiwan, South Korea, Japan, and some countries in western Europe including Switzerland, Spain, and the UK for women; and in several low-income and middle-income countries such as Eritrea, Bangladesh, Ethiopia, and Solomon Islands for men. Hypertension prevalence surpassed 50% for women in two countries and men in nine countries, in central and eastern Europe, central Asia, Oceania, and Latin America. Globally, 59% (55–62) of women and 49% (46–52) of men with hypertension reported a previous diagnosis of hypertension in 2019, and 47% (43–51) of women and 38% (35–41) of men were treated. Control rates among people with hypertension in 2019 were 23% (20–27) for women and 18% (16–21) for men. In 2019, treatment and control rates were highest in South Korea, Canada, and Iceland (treatment >70%; control >50%), followed by the USA, Costa Rica, Germany, Portugal, and Taiwan. Treatment rates were less than 25% for women and less than 20% for men in Nepal, Indonesia, and some countries in sub-Saharan Africa and Oceania. Control rates were below 10% for women and men in these countries and for men in some countries in north Africa, central and south Asia, and eastern Europe. Treatment and control rates have improved in most countries since 1990, but we found little change in most countries in sub-Saharan Africa and Oceania. Improvements were largest in high-income countries, central Europe, and some upper-middle-income and recently high-income countries including Costa Rica, Taiwan, Kazakhstan, South Africa, Brazil, Chile, Turkey, and Iran. Interpretation Improvements in the detection, treatment, and control of hypertension have varied substantially across countries, with some middle-income countries now outperforming most high-income nations. The dual approach of reducing hypertension prevalence through primary prevention and enhancing its treatment and control is achievable not only in high-income countries but also in low-income and middle-income settings. Funding WHO

    Ansiedade ao tratamento odontológico em atendimento de urgência Dental anxiety in an emergency dental service

    Get PDF
    OBJETIVO: Avaliar a freqüência de pacientes com ansiedade ou medo do tratamento odontológico em um setor de urgência. MÉTODOS: Participaram do estudo 252 pacientes, com 18 anos ou mais, que compareceram ao setor de urgência de uma faculdade de odontologia, de São Paulo, SP, entre agosto e novembro de 2001. Para avaliar a ansiedade, foram utilizadas a Modified Dental Anxiety Scale (MDAS), e a Escala de Medo de Gatchel. O grupo estudado respondeu a questões sobre: tempo decorrido desde a última visita ao dentista e desde o início dos sintomas, escolaridade, renda familiar e história prévia de trauma. Os resultados foram analisados pelos testes estatísticos (chi2 e Teste Exato de Fisher). RESULTADOS: Foram identificados 28,2% de indivíduos com algum grau de ansiedade, segundo a MDAS, na qual as mulheres foram consideradas mais ansiosas que os homens (chi2=0,01); e 14,3% de pacientes com alto grau de medo segundo a Escala de Medo de Gatchel. Em 44,4% da amostra a demora para procura de alívio dos sintomas foi > sete dias. Mulheres ansiosas procuraram atendimento mais rapidamente e em maior número. Experiência traumática anterior ocorreu em 46,5% dos pacientes ansiosos. Não foi possível relacionar escolaridade e renda familiar com ansiedade e/ou medo. CONCLUSÕES: Pacientes ansiosos, com destaque para as mulheres, são freqüentes no atendimento odontológico de urgência. Experiência prévia traumática mostrou-se importante para o desenvolvimento da ansiedade em relação ao atendimento odontológico.<br>OBJECTIVE: The purpose of the study was to assess the frequency of dental anxiety and/or fear among patients in an emergency dental service. METHODS: Research was based on interviews with 252 patients, aged 18 years old and over, attended at an emergency dentistry service of São Paulo, Brazil, from August to November, 2001. Two methods were used to measure dental anxiety: the Modified Dental Anxiety Scale (MDAS) and the Gatchel Fear Scale. The study group answered questions concerning major complaint, how much time had elapsed since their last visit to the dentist and since the initial symptoms leading to the current visit to the emergency service, level of education, family income and previous traumas. Statistical analysis (chi2 and Fisher exact test) was performed to evaluate these characteristics. RESULTS: It was found that 28.17% of this sample was dentally anxious, according to the MDAS, and 14.29%, felt fear related to dental treatment according to the Gatchel Fear Scale. Women were more anxious than men at a statistically significant rate (MDAS). The time elapsed since the onset of initial symptoms was more than 7 days for 44.44% of the participants. A large proportion of anxious women returned to treatment during the last year. A previous traumatic experience with dental was identified in 46.48% of the dentally anxious patients. No significant relation between level of education or income and dental anxiety was found. CONCLUSIONS: Dentally anxious patients frequent attend emergency care. Females are more likely to report high dental anxiety than males. Previous experience seems to be an important factor contributing to avoidance of dental care
    corecore